期刊
JOURNAL OF PHYSIOLOGY-LONDON
卷 599, 期 14, 页码 3477-3493出版社
WILEY
DOI: 10.1113/JP279376
关键词
diabetic cardiomyopathy; heart; metabolic diseases; mitochondria; oxidative stress
资金
- NIH [R01HL093671, R01HL137266, R01HL142864, R01HL122124]
- PS-1 (UAI Argentina)
- PICT [2015-3009]
Metabolic diseases are a series of pathologies characterized by abnormal body glucose usage, including metabolic syndrome, prediabetes, and diabetes mellitus types 1 and 2. These chronic diseases cause metabolic disturbances and are classified as multi-organ diseases. Mitochondria play a key role in the heart dysfunction caused by metabolic diseases.
Metabolic diseases (MetDs) embrace a series of pathologies characterized by abnormal body glucose usage. The known diseases included in this group are metabolic syndrome, prediabetes and diabetes mellitus types 1 and 2. All of them are chronic pathologies that present metabolic disturbances and are classified as multi-organ diseases. Cardiomyopathy has been extensively described in diabetic patients without overt macrovascular complications. The heart is severely damaged during the progression of the disease; in fact, diabetic cardiomyopathies are the main cause of death in MetDs. Insulin resistance, hyperglycaemia and increased free fatty acid metabolism promote cardiac damage through mitochondria. These organelles supply most of the energy that the heart needs to beat and to control essential cellular functions, including Ca2+ signalling modulation, reactive oxygen species production and apoptotic cell death regulation. Several aspects of common mitochondrial functions have been described as being altered in diabetic cardiomyopathies, including impaired energy metabolism, compromised mitochondrial dynamics, deficiencies in Ca2+ handling, increases in reactive oxygen species production, and a higher probability of mitochondrial permeability transition pore opening. Therefore, the mitochondrial role in MetD-mediated heart dysfunction has been studied extensively to identify potential therapeutic targets for improving cardiac performance. Herein we review the cardiac pathology in metabolic syndrome, prediabetes and diabetes mellitus, focusing on the role of mitochondrial dysfunctions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据